285 related articles for article (PubMed ID: 12592383)
1. Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines.
Arguello M; Sgarbanti M; Hernandez E; Mamane Y; Sharma S; Servant M; Lin R; Hiscott J
Oncogene; 2003 Feb; 22(7):964-73. PubMed ID: 12592383
[TBL] [Abstract][Full Text] [Related]
2. Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines.
Drexler HG; Meyer C; Gaidano G; Carbone A
Leukemia; 1999 Apr; 13(4):634-40. PubMed ID: 10214873
[TBL] [Abstract][Full Text] [Related]
3. Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.
Loddenkemper C; Anagnostopoulos I; Hummel M; Jöhrens-Leder K; Foss HD; Jundt F; Wirth T; Dörken B; Stein H
J Pathol; 2004 Jan; 202(1):60-9. PubMed ID: 14694522
[TBL] [Abstract][Full Text] [Related]
4. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.
Golay J; Luppi M; Songia S; Palvarini C; Lombardi L; Aiello A; Delia D; Lam K; Crawford DH; Biondi A; Barbui T; Rambaldi A; Introna M
Blood; 1996 Mar; 87(5):1900-11. PubMed ID: 8634438
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel HHV-8-positive cell line reveals implications for the pathogenesis and cell cycle control of primary effusion lymphoma.
Carbone A; Cilia AM; Gloghini A; Capello D; Fassone L; Perin T; Rossi D; Canzonieri V; De Paoli P; Vaccher E; Tirelli U; Volpe R; Gaidano G
Leukemia; 2000 Jul; 14(7):1301-9. PubMed ID: 10914556
[TBL] [Abstract][Full Text] [Related]
6. Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages.
Marecki S; Atchison ML; Fenton MJ
J Immunol; 1999 Sep; 163(5):2713-22. PubMed ID: 10453013
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease.
Torlakovic E; Tierens A; Dang HD; Delabie J
Am J Pathol; 2001 Nov; 159(5):1807-14. PubMed ID: 11696441
[TBL] [Abstract][Full Text] [Related]
8. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.
Brass AL; Zhu AQ; Singh H
EMBO J; 1999 Feb; 18(4):977-91. PubMed ID: 10022840
[TBL] [Abstract][Full Text] [Related]
9. Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma.
Hoefnagel JJ; Mulder MM; Dreef E; Jansen PM; Pals ST; Meijer CJ; Willemze R; Vermeer MH
Mod Pathol; 2006 Sep; 19(9):1270-6. PubMed ID: 16778825
[TBL] [Abstract][Full Text] [Related]
10. B-cell transcription factors Pax-5, Oct-2, BOB.1, Bcl-6, and MUM1 are useful markers for the diagnosis of nodular lymphocyte predominant Hodgkin lymphoma.
Herbeck R; Teodorescu Brînzeu D; Giubelan M; Lazăr E; Dema A; Ioniţă H
Rom J Morphol Embryol; 2011; 52(1):69-74. PubMed ID: 21424034
[TBL] [Abstract][Full Text] [Related]
11. Oct-2 and Bob-1 deficiency in Hodgkin and Reed Sternberg cells.
Re D; Müschen M; Ahmadi T; Wickenhauser C; Staratschek-Jox A; Holtick U; Diehl V; Wolf J
Cancer Res; 2001 Mar; 61(5):2080-4. PubMed ID: 11280769
[TBL] [Abstract][Full Text] [Related]
12. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene.
Marecki S; Riendeau CJ; Liang MD; Fenton MJ
J Immunol; 2001 Jun; 166(11):6829-38. PubMed ID: 11359842
[TBL] [Abstract][Full Text] [Related]
13. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.
Pileri SA; Gaidano G; Zinzani PL; Falini B; Gaulard P; Zucca E; Pieri F; Berra E; Sabattini E; Ascani S; Piccioli M; Johnson PW; Giardini R; Pescarmona E; Novero D; Piccaluga PP; Marafioti T; Alonso MA; Cavalli F
Am J Pathol; 2003 Jan; 162(1):243-53. PubMed ID: 12507907
[TBL] [Abstract][Full Text] [Related]
14. Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma.
García-Cosío M; Santón A; Martín P; Camarasa N; Montalbán C; García JF; Bellas C
Mod Pathol; 2004 Dec; 17(12):1531-8. PubMed ID: 15257313
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of multiple myeloma oncogene 1/interferon-regulatory factor 4 gene expression in malignant B-cell proliferations and normal leukocytes.
Yamada M; Asanuma K; Kobayashi D; Moriai R; Yajima T; Yagihashi A; Yamamori S; Watanabe N
Anticancer Res; 2001; 21(1B):633-8. PubMed ID: 11299818
[TBL] [Abstract][Full Text] [Related]
18. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
[TBL] [Abstract][Full Text] [Related]
19. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses.
Lacoste V; Judde JG; Bestett G; Cadranel J; Antoine M; Valensi F; Delabesse E; Macintyre E; Gessain A
Leuk Lymphoma; 2000 Jul; 38(3-4):401-9. PubMed ID: 10830748
[TBL] [Abstract][Full Text] [Related]
20. Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease.
Carbone A; Gloghini A; Gaidano G; Franceschi S; Capello D; Drexler HG; Falini B; Dalla-Favera R
Blood; 1998 Oct; 92(7):2220-8. PubMed ID: 9746758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
